Actively Recruiting
Study of PROXERA PSOMED 20 Cream and PROXERA PSOMED 40 Gel for Treating Plaque Psoriasis and Non-pustular Palmoplantar Psoriasis in Adults
Led by ICIM International S.r.l. · Updated on 2026-07-28
35
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of two CE-marked topical medical devices, PROXERA PSOMED 20 and PROXERA PSOMED 40, in people with different types of psoriasis. PROXERA PSOMED 20 is studied in participants with non-palmoplantar plaque psoriasis, while PROXERA PSOMED 40 is studied in those with non-pustular palmoplantar psoriasis. The goal is to see if applying these devices to a target area improves psoriasis compared to an untreated, similar area on the opposite side of the body. This is an interventional, single-center, randomized, single-blind study.
CONDITIONS
Brief Title
Clinical Study on the Medical Devices PROXERA PSOMED 20 and PROXERA PSOMED 40 for the Treatment of Plaque Psoriasis and Non-pustular Palmoplantar Psoriasis
Research Team
P
Paolo Amerio, Professore Ordinario
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here